Electroacupuncture for Postoperative Ileus After Laparoscopic Rectal Cancer Surgery
Can Electroacupuncture Prevent Prolonged Ileus After Laparoscopic Surgery for Mid and Low Rectal Cancer? A Prospective Study With Matched Historical Controls
1 other identifier
interventional
50
1 country
1
Brief Summary
Postoperative ileus remains a significant medical problem after colorectal surgery that adversely influences patients' recovery. The investigators previous study demonstrated that electroacupuncture (EA) at Zusanli, Sanyinjiao, Hegu, and Zhigou reduces the duration of postoperative ileus and hospital stay after laparoscopic resection of colonic and upper rectal cancer. Patients with mid/low rectal cancer undergoing laparoscopic total mesorectal excision (TME) or abdominoperineal resection (APR) were excluded. However, these complex cases are more likely to develop prolonged ileus and morbidity after surgery, and it is uncertain whether EA will be beneficial to them. The investigators therefore propose to conduct a prospective cohort study to evaluate the efficacy of EA in preventing prolonged ileus after laparoscopic surgery for mid/low rectal cancer. Fifty consecutive patients with mid/low rectal cancer undergoing laparoscopic TME or APR without the need of conversion will be recruited. All patients will undergo 1 session (20 minutes) of EA daily from postoperative day 1 till day 4. These patients will be compared with a matched historical control group (1:2) who underwent laparoscopic TME or APR without EA. The primary outcome is the incidence of prolonged ileus, which is defined as the inability to tolerate fluid diet by 4 days after surgery, associated with the need for nasogastric decompression and/or parenteral nutrition support. Secondary outcomes include time to defecation and duration of hospital stay. Results of this study will help clarify the efficacy of EA in preventing prolonged ileus after laparoscopic rectal surgery, and may provide the basis for planning a larger randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2013
CompletedStudy Start
First participant enrolled
May 1, 2013
CompletedFirst Posted
Study publicly available on registry
May 3, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedFebruary 11, 2014
February 1, 2014
1 year
April 24, 2013
February 10, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of prolonged ileus
Defined as the inability to tolerate fluid diet by 4 days after surgery, associated with the need for nasogastric decompression and/or parenteral nutrition support.
Up to 1 month
Secondary Outcomes (8)
Time of first passing flatus reported by the patients
Up to 1 month
Time to first defecation
Up to 1 month
Time that the patients tolerated solid diet
Up to 1 month
Duration of hospital stay
Up to 1 month
Pain scores on visual analog scale
Up to 3 days
- +3 more secondary outcomes
Study Arms (1)
Electroacupuncture
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Consecutive patients (aged between 18 and 80) with mid/low rectal cancer undergoing laparoscopic TME or APR without the need of conversion
- Patients with American Society of Anesthesiologists grading I-III
- Informed consent available
You may not qualify if:
- Patients undergoing simultaneous laparoscopic resection of rectal cancer and other coexisting intraabdominal diseases
- Patients undergoing laparoscopic resection of rectal cancer with en-bloc resection of surrounding organs
- Patients who developed intraoperative problems or complications (e.g. bleeding, tumor perforation) that required conversion
- Patients with intestinal obstruction
- Patients with previous history of abdominal surgery
- Patients with evidence of peritoneal carcinomatosis
- Patients who are expected to receive epidural anesthesia or analgesia
- Patients with cardiac pacemaker
- Patients who are pregnant
- Patients who are allergic to acupuncture needles
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital, The Chinese University of Hong Kong
Hong Kong SAR, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simon SM Ng, MD
Chinese University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 24, 2013
First Posted
May 3, 2013
Study Start
May 1, 2013
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
February 11, 2014
Record last verified: 2014-02